Deputy Minister Do Xuan Tuyen said that the Ministry of Health aims to complete Covid-19 vaccination for children 5 to under 12 years old in June to go to school.
The information was delivered by Deputy Minister Tuyen at the handover ceremony of 7.2 million doses of Moderna vaccine for children funded by the Australian government, on the morning of May 10. According to the Deputy Minister, the whole country has injected more than 1.85 million doses of vaccine to children of the specified age, as of May 9. Vaccines are distributed immediately after receiving them for the earliest and fastest vaccination for children.
However, the rate of vaccination for children 5-11 years old is considered too slow. Statistics of the Ministry of Health as of April 30, the North has vaccinated more than 663,800 doses, the Central region more than 123,400, the Central Highlands more than 56,000, and the South more than 677,000 doses. Meanwhile, an estimated 8.2 million children who have not yet had Covid-19 need vaccination.
Therefore, the Ministry of Health repeatedly urged the locality to speed up. In addition, this agency requires provinces and cities to accelerate the third injection for people over 18 years old, the second injection for children 12-17 years old, and plan to have the fourth injection for some groups, to be completed in the second quarter of this year. now.
Vaccines Moderna and Pfizer vaccinate children 5-11 years old, both using mRNA technology. One of the sources of vaccines used for children is funded by the Australian government, about more than 14 million doses, including more than 7.2 million doses of Moderna vaccine and more than 7.2 million doses of Pfizer.
However, Vietnam has just received the Moderna vaccine, not the Pfizer vaccine. This vaccine is indicated for children from 6 to under 12 years old, given two doses, 4 weeks apart. Each dose is 0.25 ml, which is half the dose for adults. Post-injection reactions in the group of 5-11 years old are mostly common reactions such as headache, diarrhea, pain at the injection site, possibly fatigue, slight chills and fever; occurred more frequently at the second dose than at the first dose.